| 证券代码 | CORV.O |
| 证券名称 | Correvio Pharma Corp |
| 证券类型 | 美股 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | - |
| 发行方式 | - |
| 首发上市日 | 2004-07-06 |
| 首发价格(元) | - |
| 首发数量(股) | 0 |
| 首发募资额(元) | - |
| 首发主承销商 | - |
| 货币单位 | USD |
| 公司名称 | Correvio Pharma Corp. |
| 注册地址 | 加拿大不列颠哥伦比亚省 |
| 办公地址 | 1441 Creekside Drive, 6th Floor, Vancouver, British Columbia, Canada |
| 成立日期 | 1986-12-12 |
| 董事会主席 | - |
| 公司属地 | Canada 加拿大 |
| 公司网址 | www.cardiome.com |
| 电话 | +1 (604) 677-6905 |
| 传真 | - |
| 公司简介 | Correvio Pharma Corp. is a revenue-generating, specialty pharmaceutical company focused on providing innovative, high-quality brands that meet the needs of acute care physicians and patients. With a commercial presence and distribution network covering over 60 countries worldwide, Correvio develops, acquires and commercializes brands for the in-hospital, acute care market segment. |